Falet Jean-Pierre R, Nobile Steven, Szpindel Aliya, Barile Berardino, Kumar Amar, Durso-Finley Joshua, Arbel Tal, Arnold Douglas L
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Mila - Quebec AI Institute, Montreal, QC, Canada.
Front Artif Intell. 2025 Apr 8;8:1478068. doi: 10.3389/frai.2025.1478068. eCollection 2025.
Magnetic resonance imaging (MRI) has played a crucial role in the diagnosis, monitoring and treatment optimization of multiple sclerosis (MS). It is an essential component of current diagnostic criteria for its ability to non-invasively visualize both lesional and non-lesional pathology. Nevertheless, modern day usage of MRI in the clinic is limited by lengthy protocols, error-prone procedures for identifying disease markers (e.g., lesions), and the limited predictive value of existing imaging biomarkers for key disability outcomes. Recent advances in artificial intelligence (AI) have underscored the potential for AI to not only improve, but also transform how MRI is being used in MS. In this short review, we explore the role of AI in MS applications that span the entire life-cycle of an MRI image, from data collection, to lesion segmentation, detection, and volumetry, and finally to downstream clinical and scientific tasks. We conclude with a discussion on promising future directions.
磁共振成像(MRI)在多发性硬化症(MS)的诊断、监测及治疗优化中发挥了关键作用。因其能够非侵入性地可视化病变及非病变病理状况,它是当前诊断标准的重要组成部分。然而,目前临床上MRI的使用受到冗长方案、识别疾病标志物(如病变)时容易出错的程序以及现有成像生物标志物对关键残疾结局的预测价值有限的限制。人工智能(AI)的最新进展凸显了AI不仅能改善,而且能改变MS中MRI使用方式的潜力。在这篇简短的综述中,我们探讨了AI在MS应用中的作用,这些应用涵盖了MRI图像的整个生命周期,从数据收集到病变分割、检测和容积测定,最后到下游的临床和科学任务。我们最后讨论了有前景的未来方向。